GMO GlobalSign
5.12.2023 12:07:13 CET | ACCESS Newswire | Press release
2023 was a year of expansion of the Atlas platform and increasing focus on certificate automation
BOSTON, MA / ACCESSWIRE / December 5, 2023 / GMO GlobalSign, Inc., a global Certificate Authority (CA) and leading provider of identity security, digital signing and IoT solutions, today announced the company's business highlights for 2023. A top focus for GMO GlobalSign this year has been the continued expansion of the Atlas Platform as well as an increasing call for enterprises to automate certificate management.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Atlas Platform Growth: GMOGlobalSign's digital identity platform, Atlas, was integrated with leading digital workflow company ServiceNow®. With GMO GlobalSign's PKIaaS Connector for ServiceNow, certificate management is made simpler for all ServiceNow users allowing enterprises to manage their digital certificate requests, all within their existing ServiceNow instance.
GMO GlobalSign also announced the availability of a new type of seal based on a qualified certificate. Qualified Trust Seals by DSS enable customers to quickly deploy seals at a high volume. Available through the Atlas platform, the new Qualified Trust Seals offering was created in response to customer requests for a fully automated remote signing service meeting the requirements of European Union Trust Lists. Based on our popular Digital Signing Service (DSS), GMO GlobalSign's Qualified Trust Seals allows for quick deployment, the perfect answer for organizations looking for a stress-free integration with APIs using the open source EUTL identity framework.
In addition, GlobalSign Atlas Discovery certificate scanning and reporting tool was made available. With the help of Atlas Discovery, organizations can do everything from having full accountability of all certificates, monitor network health, checking SSL/TLS certificates for common errors to understanding certificate expiration status to prevent outages.
Certificate Automation: GMO GlobalSign announced the expansion of our Automated Certificate Management Environment (ACME) service beyond Domain Validated (DV) to support Organization Validated (OV) SSL/TLS certificates, for instant verification of a company or organization.ACME OV represents a great next step towards automating SSL/TLS lifecycles and breaking into larger automation strategies for managing an organization's entire Public Key Infrastructure (PKI). This delivers strong protection for websites and businesses by activating HTTPS, reassuring an organization can completely secure all internal, as well as external communications.
Qualified Signing Service Launch: The company launched a cloud-based Qualified Signing Service (QSS) for qualified electronic signatures and seals. QSS complies with eIDAS (electronic IDentification, Authentication and trust Services), an EU regulation for electronic identification and trust services. GMO GlobalSign's Qualified Signing Service allows businesses to use mobile devices to authenticate compliantly to the QSS service enabling signatures by employees wherever they are in the world. QSS is already off to a great start, especially with European service providers who view this solution as an important new product for their customers.
Other 2023 highlights include:
- Digital signature and timestamp growth was significant. From January through early December, customers utilized our Digital Signing Service for more than 45 million signatures, while nearly 50 million timestamps were applied to a broad array of documents.
- GMO GlobalSign established partnerships with airSlate, essendi it and eXsolut GmbH.
- Our Auto Enrollment Gateway (AEG) automated certificate management tool was upgraded. The latest version offers an enhanced integration with Microsoft Intune that allows an organization to quickly provision certificates in seconds with manual intervention.
GMO GlobalSign has also worked throughout the year to impress upon companies the increasing need to automate certificate management. With decreasing certificate lifecycles - while company's endpoints are increasing - certificate management steadily becomes more difficult to manage without automation. To not do so is a risk for expirations, or worse.
In addition, the company announced achieving ISO 27701:2019 for Privacy Information Management System (PIMS) and ISO 27017:2015 for Cloud Security. GMO GlobalSign is the only certificate authority in the world to achieve this level of ISO certification. These certifications provide our customers with a guarantee that we have implemented the Information Technology industry's best-practice security methods.
"This was a year marked by a great deal of product expansion but also a tremendous focus on the need to automate the full lifecycle of certificate management. We also took steps to meet customer requests and launched new offerings like the Qualified Signing Service and Qualified Trust Seals," said Lila Kee, General Manager of the Americas, and Chief Product Officer for GMO GlobalSign. "It has been especially rewarding to see the growth of the Atlas platform. We are steadily adding capabilities which makes it a powerful tool for organizations to successfully manage their PKI."
About GMO GlobalSign
As one of the world's most deeply-rooted certificate authorities, GMO GlobalSign is the leading provider of trusted identity and security solutions enabling businesses, large enterprises, cloud-based service providers, and IoT innovators worldwide to conduct secure online communications, manage millions of verified digital identities and automate authentication and encryption. Its high-scale Public Key Infrastructure (PKI) and identity solutions support the billions of services, devices, people, and things comprising the IoT. GMO GlobalSign is a subsidiary of GMO GlobalSign Holdings, K.K., a member of the Japan-based GMO Internet Group, has offices in the Americas, Europe and Asia. For more information, visit https://www.globalsign.com.
Media Relations Contact
Amy Krigman
Director of Public Relations - West Region
Phone: 603-570-7060
Email: amy.krigman@globalsign.com
SOURCE: GMO GlobalSign
View source version on accesswire.com:
https://www.accesswire.com/813107/leading-certificate-authoritygmoglobalsigns-year-in-review
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Medical Component Specialists to Support Advanced Catheter Innovation at The Catheter R&D Masterclass in Ireland4.5.2026 21:30:00 CEST | Press release
BELLINGHAM, MA / ACCESS Newswire / May 4, 2026 / Medical Component Specialists (MCS), a premier manufacturer of precision medical components, today announced its participation as a supporting organization at The Catheter R&D Masterclass. Hosted by Eyedea Medtech, the highly anticipated event will take place May 28-29, 2026, at the Prototyping and Education Facility in Westport, Mayo, Ireland. The Catheter Systems Lab is an exclusive, dual-purpose educational program designed for senior engineers with over a decade of experience in catheter-based medical device development. Over the course of two days, industry leaders will engage in a deep exploration of catheter design, materials science, structural reinforcement, and end-to-end manufacturing pathways. As a supporting organization, Medical Component Specialists will play a vital role in the event's structured insight and data capture initiatives. The masterclass will facilitate meaningful technical dialogue, allowing MCS to gain direc
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business4.5.2026 09:30:00 CEST | Press release
LOS ANGELES, CA AND PARIS, FR / ACCESS Newswire / May 4, 2026 / Pacific Avenue Capital Partners ("Pacific Avenue"), a global private equity firm focused on corporate carve-outs and other complex transactions in the middle market, announced today that an affiliate of Pacific Avenue has entered into exclusive negotiations to acquire ESE World (the "Company" or "ESE") from Amcor, one of the world's leading global packaging companies. ESE is the foremost European manufacturer of both plastic and steel waste containers and a provider of associated waste management services. The Company generates approximately €300m of revenues and serves customers across the world from its three manufacturing facilities in Germany (Neuruppin and Olpe) and France (Crissey). Under Pacific Avenue's stewardship, ESE will focus its efforts on meeting the needs of its customers and executing several growth initiatives tied to operational improvement, geographic expansion, and strategic add-on acquisitions. Pacifi
Securitas Acquires CamVision to Expand Packaged and Advanced Security Solutions in Denmark4.5.2026 09:00:00 CEST | Press release
STOCKHOLM, SE / ACCESS Newswire / May 4, 2026 / Securitas has acquired CamVision, a Danish technology driven security specialist with a strong position in retail loss prevention and electronic security solutions. The acquisition strengthens Securitas' ability to deliver reliable and scalable security solutions for micro and small singlesite businesses as well as larger, multisite clients across Denmark. For micro and small businesses, the acquisition enhances Securitas' offering of standardized, packaged security solutions that combine proven technology with dependable service delivery. For larger and multisite clients, it further strengthens Securitas' capability to deliver advanced, technology led security systems designed for complex operational environments. "With the acquisition of CamVision, we strengthen our offering for micro and small business clients, particularly within retail. By combining proven security technology with standardized service delivery, we can offer simpler,
Formerra Appoints Matt Borowiec as Chief Commercial Officer1.5.2026 15:00:00 CEST | Press release
CLEVELAND, OH / ACCESS Newswire / May 1, 2026 / Formerra, a leading distributor of performance materials, today announced the appointment of Matt Borowiec as Chief Commercial Officer (CCO). Borowiec will lead the company's commercial organization to support continued growth and global expansion while strengthening sales execution and customer success. Borowiec is a seasoned executive with over 25 years' experience in operations, commercial and P&L roles across resin manufacturing, specialty compounding, and distribution, including leadership roles at GE Plastics, PolyOne (now Avient), Transcendia, Celanese, and Kinsley Group. With this background, he is well positioned to lead Formerra's commercial strategy at this important time in the company's evolution. "Matt brings a unique combination of producer‑side and distribution experience that positions him well to strengthen alignment between our suppliers, customers, and commercial teams," said Tom Kelly, Chief Executive Officer at Forme
Global Experts call for Paradigm Shift in Medicine, Health and Education to Save Lives and Fight Escalating Health Crisis1.5.2026 14:48:00 CEST | Press release
INNSBRUCK, AUSTRIA / ACCESS Newswire / May 1, 2026 / A global consortium of 64 experts (72 entities, 5 continents) unveiled two coordinated consensus plus policy brief reports, outlining a science‑driven roadmap to confront escalating health crises and to tackle the growing burden of noncommunicable diseases (NCDs-including cardiovascular diseases, cancer, diabetes, etc.: 75% of global deaths; 82% in low-/middle income countries; 90% of all death in European region). The centerpiece is HEAL-Healthy Eating & Active Living, ideally whole‑food plant‑predominant/vegetarian-vegan diets & daily exercise outdoors/active mobility-as the minimum, first‑line standard in health and care. The authors urge immediate action on Prevention-over-Treatment and reforming education and human‑relevant science (drug failure rate from animal studies is 90-95%, and as high as 99.6% for Alzheimer disease), with a rapid shift from disease‑centered reaction to person‑centered, lifestyle‑first cure and care. Figu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom